FDA Inspection 1117796 — Jacques Hebert MD
The FDA completed an inspection of Jacques Hebert MD on February 7, 2020 in Quebec. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- February 7, 2020
- Fiscal Year
- 2020
- Product Type
- Biologics
- Project Area
- Bioresearch Monitoring
- Location
- Quebec (Canada)
Additional Details
Clinical Investigator (CI)